Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Apr;13(2):178-80.
doi: 10.2450/2015.0002-15.

The treatment of venous thromboembolism with novel oral anticoagulants: warnings and limitations

Paolo Prandoni  1
Affiliations
Review

The treatment of venous thromboembolism with novel oral anticoagulants: warnings and limitations

Paolo Prandoni. Blood Transfus. 2015 Apr.
No abstract available

PubMed Disclaimer

Comment in

References

    1. Prandoni P. Venous thromboembolism in 2013: the advent of the novel oral anticoagulants. Nat Rev Cardiol. 2014;11:70–2. - PubMed
    1. van Es N, Coppens M, Schulman S, et al. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood. 2014;124:1968–75. - PubMed
    1. Cohen AT, Imfeld S, Rider T. Phase III trials of new oral anticoagulants in the acute treatment and secondary prevention of VTE: comparison and critique of study methodology and results. Adv Ther. 2014;31:473–93. - PMC - PubMed
    1. Prandoni P, Barbar S, Vedovetto V, et al. Treatment of venous thromboembolism: the single-drug approach. Clin Pract. 2013;10:607–13.
    1. Prandoni P, Barbar S, Milan M, et al. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests. Thromb Haemost. 2014 doi: 10.1160/TH14-04-0396. - DOI - PubMed

MeSH terms